己酮可可碱缓释片在健康受试者中单中心、随机、开放、
单剂量、两制剂、空腹和餐后状态下的生物等效性试验
[Translation] A single-center, randomized, open-label, open-label study of pentoxifylline extended-release tablets in healthy subjects
Bioequivalence studies in single dose, two formulations, fasting and postprandial states
以广东君康药业有限公司提供的己酮可可碱缓释片为受试制剂,按生物等效性试验的有关规定,以Sanofi生产的己酮可可碱缓释片(商品名:TRENTAL®)为参比制剂,对比在中国健康成年受试者中空腹及餐后给药条件下人体内的吸收速度及吸收程度药代动力学特征,评价两种制剂的生物等效性。
[Translation] Pentoxifylline sustained-release tablets provided by Guangdong Junkang Pharmaceutical Co., Ltd. were used as the test preparation. According to the relevant regulations of bioequivalence testing, pentoxifylline sustained-release tablets (trade name: TRENTAL®) produced by Sanofi were used. As a reference preparation, the bioequivalence of the two preparations was evaluated by comparing the absorption rate and pharmacokinetic characteristics of the absorption degree in Chinese healthy adult subjects under fasting and postprandial administration conditions.
100 Clinical Results associated with GuangDong Junkang Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with GuangDong Junkang Pharmaceutical Co., Ltd.
100 Deals associated with GuangDong Junkang Pharmaceutical Co., Ltd.
100 Translational Medicine associated with GuangDong Junkang Pharmaceutical Co., Ltd.